Drug Week
Susan Hasty, Publisher
Table of Contents . . . November 15th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Alzheimer Disease - OHSU takes part in unique treatment trial
Dementia - Alzheimer drug effective against vascular dementias
Adverse Drug Effects - Frequency of new type 2 diabetes evaluated in patients taking antipsychotics
Genital Herpes - Therapeutic vaccine's safety shown in clinical evaluation
Influenza - FluINsure vaccine results presented at ICAAC
Pulmonary Embolism - Abbott receives FDA approval to reintroduce Abbokinase
Sickle Cell Anemia - Fast track status announced for novel sickle cell anemia treatment
Urology - First dual-acting 5 alpha-reductase inhibitor approved for benign prostatic hyperplasia
Addiction Medicine - Worldwide license agreement for potential drug treatment announced
Anxiety Disorders - Expansion of Ampakine research collaboration announced
Appointments - Joseph Villafranca joins Neose executive team
Appointments - Oral medicines developer names expert in antiviral discovery and development as CEO
Appointments - Pharmaceutical company announces board and management changes
Appointments - Sleep, neurological products developer selects new worldwide drug development VP
Cancer Therapies - Agreement reached for development, commercialization of indolocarbazole
Cancer Therapy - NDA submitted for antiemetic
Chronic Myeloid Leukemia - NCI/CALGB trial of Genasense plus Gleevec begins
Chronic Obstructive Pulmonary Disease - Positive forecast made for tiotropium
Cystic Fibrosis - Collaboration funds phase II study of respiratory therapeutic
Diagnostics - Skin cholesterol consumer products may help determine heart disease risk
Drug Delivery - Web site details patented technology
Drug Design - RNA drug technology shows therapeutic promise against bioterror agents
Drug Development - Bristol-Myers Squibb receives FDA action letter on antihypertension drug
Drug Development - Collaboration focuses on therapeutics on G protein-coupled receptors
Drug Development - Launching pharmaceutical blockbusters: Investing early fuels maximum impact
Drug Development - Molecular regeneration medicine developer signs multiyear collaborations with Abbott Labs
Drug Discovery - AstraZeneca renews global license of simulation software
Drug Discovery - GPCR-targeted library used to discover a small molecule agonist
Drug Discovery - NIST grant awarded for clinical genomics software development
Endocrinology - Exclusive license for thyroid stimulating hormone suppressor announced
Endocrinology - New FDA-cleared calcitonin test launched in U.S., Europe
Ethics - Critics call researchers' ties to drug companies troubling
Female Sexual Dysfunction - Phase II clinical trial initiated for testosterone gel
Gastroenterology - Company acquires marketing rights to rectal gel mesalamine preparation
Gastroenterology - Protein therapeutic significantly reduces tissue necrosis, mucosal damage
HIV/AIDS Therapy - Novel method for viral reservoir eradication shows promise
HIV/AIDS Therapy - Novel noncytotoxic vaginal microbicide may help prevent HIV and other infections
HIV/AIDS Therapy - Vitamin E can prevent infection-induced T-cell apoptosis
Hepatitis C Therapy - PEGylated Infergen to be developed for hepatitis C infection
Hypertension - Atorvastatin decreases incidence of heart disease, stroke
Laboratory Techniques - High-throughput cell analyzer 'Opera' launched
Legal Issues - Progress of pending patent protection for Levoxyl updated
Neurodegeneration - Aegera grants Wyeth license to adenovirus technology
Non-Small Cell Lung Cancer - Phase III clinical trial of Xyotax for second-line treatment initiated
Ophthalmology - ISTA Pharmaceuticals submits CMC section of Vitrase NDA
Ophthalmology - Results of phase I/II trial in retinal detachment announced
Pharmacy Benefit Plans - Employers shifting more decision-making, financial responsibility to employees
Prostate Cancer - License and codevelopment agreement signed for late-stage drug
Pulmonary Medicine - Canada's drug authority approves Remodulin for pulmonary arterial hypertension
Regulatory Issues - Court overturns rules on pediatric drug testing
Respiratory Disease - Collaboration combines technologies for novel therapeutics
Respiratory Disease - Peptides for humanized pulmonary surfactant technology patented
Restenosis - Safety data reported from drug-eluting stent clinical trial
Schizophrenia - Newer generation, long-acting injectable antipsychotic improves quality of life
Schizophrenia - Patients with intolerance to one drug benefit by switch to quetiapine fumarate
Stem Cell Transplantation - Anti-CD40L antibody effects enhanced by immunosuppressive agents
Stroke - sNDA filed for Niaspan for reducing risk
Therapies - Growth in the U.S. diabetes markets lures pharmaceutical companies
Thrombosis - Phase I/II study of antiphospholipid syndrome immunotherapeutic discussed
Transgenic Medicine - Dow obtains patents for production of glycoproteins in plant systems
Transplant Medicine - Recruitment complete for phase IIa clinical trial in kidney transplantation
Ulcerative Colitis - Phase III trial for increased dosage mesalamine underway
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
